Fox Run Management, L.L.C. Axonics, Inc. Transaction History

Fox Run Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$49.38 - $63.75 $266,405 - $343,931	5,395 New	5,395 $335,000
Q1 2023 May 12, 2023	BUY	$52.6 - $67.34 $346,634 - $443,770	6,590 New	6,590 $359,000
Q3 2022 Nov 07, 2022	BUY	$57.96 - $78.12 $167,388 - $225,610	2,888 New	2,888 $203,000
Q2 2022 Aug 12, 2022	SELL	$39.5 - $64.42 $215,907 - $352,119	-5,466 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$43.74 - $62.76 $239,082 - $343,046	5,466 New	5,466 $342,000

221

42M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.